ArticleHealth science reports2025
Indications and Findings of Upper Gastrointestinal Endoscopy at a District Hospital in Ghana: A Retrospective Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analysis of Histopathological Lesions and Their Correlation With Upper Gastrointestinal Endoscopic Findings: A Retrospective Study at a District Hospital in Ghana.Health science reports · 2026Article
- Gastro-oesophageal reflux disease symptom subtypes and endoscopy findings: a retrospective, cross-sectional study from Southwestern Nigeria.BMC gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Gastrointestinal diseases are a significant global health issue, with symptoms from these conditions negatively affecting quality of life and causing substantial economic consequences. Esophagogastroduodenoscopy, also referred to as upper gastrointestinal endoscopy, is an important and safe procedure used for both diagnosis and treatment in the field of gastroenterology. This study sought to assess the characteristic clinical indications and endoscopic findings of individuals presenting at Methodist Hospital, Wenchi, Ghana. Methods: A retrospective analysis was conducted by examining the medical records of patients who underwent upper gastrointestinal endoscopy from April 2023 to June 2024. Results: Out of 405 patients who underwent upper gastrointestinal endoscopy during the study period, 396 were included in the subsequent analysis. The average age of patients was 43.7 years with a standard deviation of 16.6 and ranging from 12 to 100 years. Approximately 42.9% of the patients were males. Dyspepsia was the most common reason for upper gastrointestinal endoscopy (60.9%), followed by retrosternal chest pain (17.7%), heartburn (12.1%) and upper gastrointestinal bleeding (3.8%). Results of upper gastrointestinal endoscopy were normal in 15.2% of patients. The most prevalent pathologies of the esophagus, stomach and duodenum were gastroesophageal reflux disease (17.4%), gastritis (31.8%), and duodenitis (4.5%), respectively. Conclusion: Dyspepsia was the primary indication for endoscopic evaluation of the upper gastrointestinal tract. The most prevalent pathological finding was gastritis, followed by gastroesophageal reflux disease, gastric ulcer, hiatal hernia and duodenitis. Esophagogastroduodenoscopy is an essential investigative tool for diagnosing upper gastrointestinal tract pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.